p16 gene methylation in colorectal cancers associated with Duke's staging

World Journal of Gastroenterology

Volumn 7, Issue 5, 2001, Pages 722-725

  Yi, J ^a   Wang, Z W ^a   Cang, H ^a   Chen, Y Y ^a   Zhao, R ^a   Yu, B M ^a   Tang, X M ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P16;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PATIENT CODING; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

EID: 0034771582     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v7.i5.722     Document Type: Article

References (47)

1. INK4a/CDKN2A tumor suppressor and its relatives
2. INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer
3. Alterations in DNA methylation: A fundamental aspect of neoplasia
4. Association of K-ras mutations with p16 methylation in human colon cancer
5. Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: Association with DNA replication error and shorter survival
6. DNA methylation
7. Cancer epigenetics comes of age
8. Undermethylation associated with retroelement activation and chromosome remodelling in an interspecific mammalian hybrid
9. DNA hypomethylation leads to elevated mutation rates
10. Involvement of DNA methylation in human carcinogenesis
11. DNA methylation and genetic instability in colorectal cancer cells
12. Role of the p16 tumor suppressor gene in cancer
13. Gene silencing in the development of cancer
14. INK4 mediates contact inhibition of growth
15. 5′CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
16. p16 gene and digestive tract neoplasms
17. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients
18. P16/MTSI/INK4A gene is frequently inactivated by hypermethylation in childhood acute lymphoblastic leukemia with 11q23 translocation
19. p16 (INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma
20. Aberrant promoter methylation of multiple genes in non small cell lung cancers
21. K-ras and p16 aberrations confer poor prognosis in human colorectal cancer
22. High frequency of homozygous deletion and methylation of p16 (INK4A) gene in oral squamous cell carcinomas
23. Methylation of the p16 (Ink4a) tumor suppressor gene 5′CpG island in breast cancer
24. Frequency of p16 (INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver
25. Mutations, methylation and expression of CDKN2a/p16 gene in colorectal cancer and normal colonic mucosa
26. Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer
27. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients
28. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia
29. P16 gene and APC gene mutation in gastrinomas
30. DNA methylation and carcinogenesis in digestive neoplasms
31. Methylation of the 5′CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing
32. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
33. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status
34. DNA methylation is a reversible biological signal
35. Study on p16 gene aberrant methylation of colon cancer cell lines
36. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression
37. Methylation status of p16 gene in colorectal carcinoma and normal colonic mucosa
38. Methylation status of p16 gene in colorectal carcinoma and normal colonic mucosa
39. CpG island methylator phenotype in colorectal cancer
40. Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas
41. Hypermethylation of the p16/CDKN2A/MTS1 gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas
42. Frequent hypermethylation of p16 and p15 genes in multiple myeloma
43. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis
44. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis
45. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction
46. Immunohistochemical study of p16 gene alteration in colorectal cancer
47. Activation but not inactivation of the MTS1 gene is associated with primary colorectal carcinomas